Brief: Pharnext Announces Reinforcement Of Equity Capital By Conversion Of Convertible Bonds
06/03/2019 17:49
March 6 (Reuters) - PHARNEXT SA PHARN.PA :
* AFTER CONVERSION, TASLY WILL HOLD 15.89% OF PHARNEXT
ISSUED
CAPITAL
* PHARNEXT: REINFORCEMENT OF PHARNEXT EQUITY CAPITAL BY
CONVERSION
OF CONVERTIBLE BONDS
* IMPLEMENTATION OF CONVERSION OF ALL OF CONVERTIBLE BONDS
HELD BY
TASLY, A LEADING CHINESE PHARMACEUTICAL GROUP, FOR A TOTAL
AMOUNT OF EUR 25 MILLION
* CONVERSION PRICE OF EUR13 REPRESENTED A PREMIUM OF GREATER
THAN
50% IN CONNECTION WITH STOCK MARKET PRICE AT TIME
Source text for Eikon: ID:nEQbDsq07a
Further company coverage: PHARN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development